Loading...
XSHE
300412
Market cap409mUSD
Dec 05, Last price  
5.81CNY
1D
1.93%
1Q
11.30%
Jan 2017
-39.23%
IPO
121.51%
Name

Zhejiang Canaan Technology Ltd

Chart & Performance

D1W1MN
XSHE:300412 chart
P/E
79.74
P/S
2.09
EPS
0.07
Div Yield, %
Shrs. gr., 5y
2.92%
Rev. gr., 5y
14.49%
Revenues
1.38b
+32.09%
138,210,327152,084,830154,249,253183,810,026217,418,447301,792,829445,032,263578,756,391703,164,5461,007,249,1681,059,613,8691,103,431,0121,047,093,8911,383,110,540
Net income
36m
P
33,635,21536,214,95434,719,42642,762,13551,454,25257,040,40643,963,92933,632,54551,314,22667,905,49273,697,3750-23,433,46736,266,978
CFO
119m
P
21,190,07733,814,27920,846,95038,900,44139,955,51024,678,9080041,507,67555,469,48875,025,26268,616,352-53,646,586119,463,611
Dividend
Jun 09, 20220.102 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhejiang Canaan Technology Co., Ltd. engages in the development, manufacture, and marketing of pharmaceutical equipment in China. The company offers OSD products, such as dispensing, high shear mixer, roller compactor, fluid bed, mill, pelleting, lender, pharma lifter, tablet press, coater, capsule filling, washing machine, and pharma bin and series parts, as well as OEB equipment and isolators, R&D machines, APIs, packaging, water systems, extraction and reactor, and warehouse products. It primarily serves pharmaceutical industry. Zhejiang Canaan Technology Co., Ltd. was founded in 2000 and is based in Wenzhou, China.
IPO date
Dec 31, 2014
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT